《大行報告》美銀證券降中國建築(03311.HK)目標價至12元 業績穩健
美銀證券發表報告指,中國建築(03311.HK)業績穩健,去年純利92億元,按年升15%,符合該行預期,當中的驚喜包括股本回報按年提升1.4個百分點至15.3%;來自內地的經營現金流轉向正面;派息比率上升0.4個百分點至30.8%;新訂單按年提升17%,其中香港市場新訂單增加58%。
該行相信公司以往盈利穩定增長的紀錄,以及營運狀況全面改善,將爲投資者提供更大信心,維持其「買入」評級,並將今明兩年盈利預測上調1%,相信股息率8%屬吸引水平。因應調整市盈率指標時期,將其目標價由14.2元下調至12元。(cy/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.